Study supports cardiovascular safety of naproxen
14th Nov 2006, 06:12 GMT
A new study of the over-the-counter pain reliever naproxen has confirmed the cardiovascular safety of the drug, which is used in the treatment of arthritis and for other pain relief.
Study supports cardiovascular safety of naproxen related news:
- Study Provides Further Support for Cardiovascular Safety of OTC Doses of Naproxen Sodium — Cardiology News from StratCenter.com
- Aleve Heart-Healthy Over Short-Term — iVillage Health & Well-Being News
- AHA: Arcoxia (etoricoxib) May Not Increase Risk of Cardiovascular Events — MedPage Today Rheumatology
- Diabetes drug may reduce cardiovascular risks — EurekAlert! - Medicine and Health
- Study Confirms Folic Acid, B Vitamins Do Not Prevent Cardiovascular Events — Medscape PublicHealth Headlines
- Study: Painkiller naproxen safe for heart — CNN.com - Health
- Painkiller naproxen safe for heart, study suggests — CNN.com - Health
- Children's Safety Gear : Not Safe Enough — The Earth Times Online Newspaper
- Results Mixed on Merck's New Painkiller — Sci-Tech Today
- Riverside ranked among tops for cardiovascular care — Latest news from Business First of Columbus
Latest news from Pharmaceutical Business Review Latest News:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol
- ZymoGenetics, Serono present positive results for atacicept